Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [³H]UR-MK136: a highly potent and selective radioligand for neuropeptide Y Y₁ receptors.

× No keyword cloud information.

4 in total

1. Prototypic ¹⁸F-Labeled Argininamide-Type Neuropeptide Y Y₁R Antagonists as Tracers for PET Imaging of Mammary Carcinoma.

Authors: Max Keller; Simone Maschauer; Albert Brennauer; Philipp Tripal; Norman Koglin; Ralf Dittrich; Günther Bernhardt; Torsten Kuwert; Hans-Jürgen Wester; Armin Buschauer; Olaf Prante
Journal: ACS Med Chem Lett Date: 2017-02-21 Impact factor: 4.345

2. Argininamide-type neuropeptide Y Y₁ receptor antagonists: the nature of N ^ω-carbamoyl substituents determines Y₁R binding mode and affinity.

Authors: Jonas Buschmann; Theresa Seiler; Günther Bernhardt; Max Keller; David Wifling
Journal: RSC Med Chem Date: 2020-01-20

3. An Alkyne-functionalized Arginine for Solid-Phase Synthesis Enabling "Bioorthogonal" Peptide Conjugation.

Authors: Katrin Spinnler; Lara von Krüchten; Adam Konieczny; Lisa Schindler; Günther Bernhardt; Max Keller
Journal: ACS Med Chem Lett Date: 2019-09-30 Impact factor: 4.345

4. In Search of NPY Y₄R Antagonists: Incorporation of Carbamoylated Arginine, Aza-Amino Acids, or d-Amino Acids into Oligopeptides Derived from the C-Termini of the Endogenous Agonists.

Authors: Kilian K Kuhn; Timo Littmann; Stefanie Dukorn; Miho Tanaka; Max Keller; Takeaki Ozawa; Günther Bernhardt; Armin Buschauer
Journal: ACS Omega Date: 2017-07-14

4 in total

[³H]UR-MK136: a highly potent and selective radioligand for neuropeptide Y Y₁ receptors.

1. Prototypic 18F-Labeled Argininamide-Type Neuropeptide Y Y1R Antagonists as Tracers for PET Imaging of Mammary Carcinoma.

2. Argininamide-type neuropeptide Y Y1 receptor antagonists: the nature of N ω-carbamoyl substituents determines Y1R binding mode and affinity.

3. An Alkyne-functionalized Arginine for Solid-Phase Synthesis Enabling "Bioorthogonal" Peptide Conjugation.

4. In Search of NPY Y4R Antagonists: Incorporation of Carbamoylated Arginine, Aza-Amino Acids, or d-Amino Acids into Oligopeptides Derived from the C-Termini of the Endogenous Agonists.

1. Prototypic ¹⁸F-Labeled Argininamide-Type Neuropeptide Y Y₁R Antagonists as Tracers for PET Imaging of Mammary Carcinoma.

2. Argininamide-type neuropeptide Y Y₁ receptor antagonists: the nature of N ^ω-carbamoyl substituents determines Y₁R binding mode and affinity.

4. In Search of NPY Y₄R Antagonists: Incorporation of Carbamoylated Arginine, Aza-Amino Acids, or d-Amino Acids into Oligopeptides Derived from the C-Termini of the Endogenous Agonists.